109 related articles for article (PubMed ID: 14707458)
21. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
22. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.
Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
Clin Cancer Res; 1999 Oct; 5(10):2848-53. PubMed ID: 10537352
[TBL] [Abstract][Full Text] [Related]
23. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
24. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic expression of p27(kip1) is associated with a favourable prognosis in colorectal cancer patients.
Watson NF; Durrant LG; Scholefield JH; Madjd Z; Scrimgeour D; Spendlove I; Ellis IO; Patel PM
World J Gastroenterol; 2006 Oct; 12(39):6299-304. PubMed ID: 17072952
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of p27 in gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; von Boguslawski K; Haglund C
Oncology; 2002; 63(2):180-4. PubMed ID: 12239454
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.
Tenjo T; Toyoda M; Okuda J; Watanabe I; Yamamoto T; Tanaka K; Ohtani M; Nohara T; Kawasaki H; Tanigawa N
Oncology; 2000; 58(1):45-51. PubMed ID: 10644940
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of STAT1 and p21 proteins predicts pancreatic cancer progression and prognosis.
Sun Y; Yang S; Sun N; Chen J
Pancreas; 2014 May; 43(4):619-23. PubMed ID: 24658320
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
30. Cyclin-dependent kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer.
Schmider-Ross A; Pirsig O; Gottschalk E; Denkert C; Lichtenegger W; Reles A
J Cancer Res Clin Oncol; 2006 Mar; 132(3):163-70. PubMed ID: 16328436
[TBL] [Abstract][Full Text] [Related]
31. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
[TBL] [Abstract][Full Text] [Related]
32. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
34. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
[TBL] [Abstract][Full Text] [Related]
35. Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma.
Kouvaraki MA; Korapati AL; Rassidakis GZ; Tian L; Zhang Q; Chiao P; Ho L; Evans DB; Claret FX
Cancer Res; 2006 Sep; 66(17):8581-9. PubMed ID: 16951171
[TBL] [Abstract][Full Text] [Related]
36. The role of p27 in endometrial carcinoma.
Nycum LR; Smith LM; Farley JH; Kost ER; Method MW; Birrer MJ
Gynecol Oncol; 2001 May; 81(2):242-6. PubMed ID: 11330957
[TBL] [Abstract][Full Text] [Related]
37. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
[TBL] [Abstract][Full Text] [Related]
38. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.
Itami A; Shimada Y; Watanabe G; Imamura M
Oncology; 1999 Nov; 57(4):311-7. PubMed ID: 10575318
[TBL] [Abstract][Full Text] [Related]
40. Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer.
Pertia A; Nikoleishvili D; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A
Int Urol Nephrol; 2007; 39(2):381-7. PubMed ID: 17310312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
